All Stories

  1. Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients

    Article • European Respiratory Journal, December 2020, European Respiratory Society (ERS)

    Jinping Zheng

  2. Impaired pulmonary function in discharged patients with COVID-19: More work ahead

    Article • European Respiratory Journal, June 2020, European Respiratory Society (ERS)

    Jinping Zheng

  3. Carbocisteine inhibits the expression of Muc5b in COPD mouse model

    Article • Drug Design Development and Therapy, September 2019, Taylor & Francis

    Jinping Zheng

  4. The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial)

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, September 2018, Taylor & Francis

    Dr Aik H Goh, David Lipson, Jinping Zheng

  5. Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2016, Dove Medical Press

    Jinping Zheng

  6. Efficacy and safety of once-daily inhaled umeclidinium/vilanterol in Asian patients with COPD: results from a randomized, placebo-controlled study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2015, Dove Medical Press

    Dr Aik H Goh, Jinping Zheng

  7. Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of China

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2014, Taylor & Francis

    Dr Jing Zhang, Professor Chunxue Bai, Dr. Huan-Zhong Shi, Baiqiang Cai, Jinping Zheng